Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 29, 2021 at 09:02 am
Share
Guangdong Biolight Meditech Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 506.524 million compared to CNY 776.856 million a year ago. Operating income was CNY 62.470 million compared to CNY 288.475 million a year ago. Net income was CNY 52.743 million compared to CNY 240.017 million a year ago. Basic earnings per share from continuing operations was CNY 0.361 compared to CNY 1.643 a year ago.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. 
